The company manufactures various grades of cement and operates solar power facilities in Karnataka, using the energy for its own production and selling the surplus to external consumers.
The company possesses a narrow cost advantage derived from its captive solar power model, which significantly lowers energy expenses compared to peers. However, this is offset by the lack of captive limestone mines, forcing reliance on external purchases and weakening the overall structural advantage.
Management has heavily reinvested in expanding cement capacity and solar assets, funded by a mix of debt and equity. While these investments aim for cost efficiency, the track record is marred by high leverage and historically poor returns on equity.
The company's collapse was driven by a debt trap where interest obligations consistently outpaced operating cash flow, as evidenced by an interest coverage ratio already below 1.0. The lack of captive limestone mines forced the firm to buy raw materials at market rates while cement prices stagnated, squeezing margins until the solar cost advantage was irrelevant. Eventually, the combination of the DGGI tax investigation and the inability to refinance high-leverage debt led to a liquidity crisis, forcing a fire sale of assets or dilutive equity raises that wiped out existing shareholders.
RichFakir rates Shri Keshav Cements & Infra Ltd's business quality as poor — 32/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Shri Keshav Cements & Infra Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shri Keshav Cements & Infra Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Shri Keshav Cements & Infra Ltd's fair value is about ₹12 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →